Haverkorn M J
J Hosp Infect. 1987 May;9(3):249-54. doi: 10.1016/0195-6701(87)90121-6.
A multi-centre double-blind, placebo-controlled clinical trial was performed to determine the minimum number of doses of metronidazole required for effective prophylaxis of vaginal cuff abscess following hysterectomy. Four hundred and seventy-five patients received zero, one, two, three, six or twenty-one 500 mg doses of metronidazole. Data from 440 patients were analysed and showed that one dose of metronidazole markedly reduced the risk of vaginal cuff abscess in patients undergoing vaginal hysterectomy. The effect on vaginal cuff cellulitis was not evident. It is concluded that one preoperative dose of 500 mg metronidazole is an effective, convenient and cheap prophylaxis for patients undergoing vaginal hysterectomy.
进行了一项多中心双盲、安慰剂对照临床试验,以确定子宫切除术后有效预防阴道断端脓肿所需的甲硝唑最小剂量。475例患者接受了0、1、2、3、6或21剂500毫克的甲硝唑。对440例患者的数据进行分析后发现,一剂甲硝唑可显著降低接受阴道子宫切除术患者发生阴道断端脓肿的风险。对阴道断端蜂窝织炎的影响不明显。结论是,术前一剂500毫克甲硝唑对接受阴道子宫切除术的患者是一种有效、方便且廉价的预防措施。